Liberty Mutual Group Asset Management Inc. Edwards Lifesciences Corp Transaction History

Liberty Mutual Group Asset Management Inc.

$679 Million
Q2 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$46.41 - $56.94 $391,004 - $479,719	-8,425 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$42.45 - $51.3 $382 - $461	9 Added 0.11%	8,425 $1.23 Million
Q4 2017 Feb 12, 2018	SELL	$33.79 - $39.39 $38,148 - $44,471	-1,129 Reduced 11.83%	8,416 $949,000
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $346,388 - $370,632	9,545	9,545 $1.04 Million

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

Vanguard Group Inc Valley Forge, PA

53.6M
Shares

$3.51 Billion
0.1% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.34 Billion
0.11% of portfolio
State Street Corp Boston, MA

26M
Shares

$1.7 Billion
0.11% of portfolio
Alliancebernstein L.P. New York, NY

20.3M
Shares

$1.33 Billion
0.68% of portfolio
Wellington Management Group LLP Boston, MA

16.9M
Shares

$1.11 Billion
0.29% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Liberty Mutual Group Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Liberty Mutual Group Asset Management Inc. with notifications on news.

Account